MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.50
-0.85 (-6.88%)
At close: Dec 5, 2025, 4:00 PM EST
11.73
+0.23 (2.00%)
After-hours: Dec 5, 2025, 5:50 PM EST
MiNK Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 14.28 | 4.58 | 3.37 | 19.64 | 38.89 | 2.69 | Upgrade
|
| Cash & Short-Term Investments | 14.28 | 4.58 | 3.37 | 19.64 | 38.89 | 2.69 | Upgrade
|
| Cash Growth | 125.67% | 35.93% | -82.85% | -49.51% | 1345.06% | 799.94% | Upgrade
|
| Other Receivables | - | - | - | - | - | 0.25 | Upgrade
|
| Receivables | - | - | - | - | - | 0.25 | Upgrade
|
| Prepaid Expenses | 0.25 | 0.25 | 0.05 | 0.3 | 0 | 0.49 | Upgrade
|
| Other Current Assets | 0 | 0.16 | 0.18 | 0.47 | 0.74 | 0.66 | Upgrade
|
| Total Current Assets | 14.53 | 4.99 | 3.6 | 20.4 | 39.63 | 4.1 | Upgrade
|
| Property, Plant & Equipment | 0.43 | 0.73 | 0.95 | 1.07 | 0.61 | 0.46 | Upgrade
|
| Total Assets | 14.96 | 5.72 | 4.55 | 21.47 | 40.24 | 4.56 | Upgrade
|
| Accounts Payable | 3.69 | 2.73 | 3.91 | 5.82 | 3 | 3.14 | Upgrade
|
| Accrued Expenses | 1.26 | 1.87 | 5.04 | 4.24 | 1.76 | 1.86 | Upgrade
|
| Other Current Liabilities | 2.76 | 2.36 | 2.45 | 2.62 | 11.71 | 9.22 | Upgrade
|
| Total Current Liabilities | 13.43 | 6.96 | 11.4 | 12.68 | 16.47 | 14.22 | Upgrade
|
| Long-Term Debt | - | 4.92 | - | - | - | 43.82 | Upgrade
|
| Other Long-Term Liabilities | 15.04 | 13.42 | 11.21 | 9.19 | - | 0.38 | Upgrade
|
| Total Liabilities | 28.48 | 25.31 | 22.61 | 21.87 | 16.47 | 58.43 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 141.25 | 125.23 | 115.77 | 110.83 | 107.35 | 0.38 | Upgrade
|
| Retained Earnings | -154.07 | -144.18 | -133.4 | -110.94 | -82.95 | -52.74 | Upgrade
|
| Comprehensive Income & Other | -0.69 | -0.63 | -0.43 | -0.29 | -0.63 | -1.52 | Upgrade
|
| Shareholders' Equity | -13.51 | -19.59 | -18.06 | -0.4 | 23.78 | -53.87 | Upgrade
|
| Total Liabilities & Equity | 14.96 | 5.72 | 4.55 | 21.47 | 40.24 | 4.56 | Upgrade
|
| Total Debt | 5.73 | 4.92 | - | - | - | 43.82 | Upgrade
|
| Net Cash (Debt) | 8.56 | -0.35 | 3.37 | 19.64 | 38.89 | -41.13 | Upgrade
|
| Net Cash Growth | 398.43% | - | -82.85% | -49.51% | - | - | Upgrade
|
| Net Cash Per Share | 2.09 | -0.09 | 0.98 | 5.83 | 14.94 | -17.06 | Upgrade
|
| Filing Date Shares Outstanding | 4.69 | 3.97 | 3.47 | 3.39 | 3.36 | 2.42 | Upgrade
|
| Total Common Shares Outstanding | 4.6 | 3.96 | 3.46 | 3.39 | 3.35 | 2.42 | Upgrade
|
| Working Capital | 1.1 | -1.97 | -7.8 | 7.72 | 23.17 | -10.13 | Upgrade
|
| Book Value Per Share | -2.94 | -4.94 | -5.22 | -0.12 | 7.10 | -22.28 | Upgrade
|
| Tangible Book Value | -13.51 | -19.59 | -18.06 | -0.4 | 23.78 | -53.87 | Upgrade
|
| Tangible Book Value Per Share | -2.94 | -4.94 | -5.22 | -0.12 | 7.10 | -22.28 | Upgrade
|
| Machinery | 1 | 1.26 | 1.45 | 1.35 | 0.78 | 0.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.